Boris N Kholodenko

13PUBLICATIONS
42CO-AUTHORS
Respiratory diseasesInnate immunityMechanobiologyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 31, 2026
Polycomb Repressive Complex 2 drives flow-sensitive endothelial states underlying vascular inflammation and disease.

|Jul 17, 2026
IFN𝛾 and IFN𝛾 mimetics prevent IFN-I-mediated TB susceptibility by regulating iron metabolism and lipid peroxidation.

|Oct 02, 2025
Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility.

Shivraj M Yabaji, Vadim Zhernovkov, Prasanna Babu Araveti

|Jul 14, 2025
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.

Luke Jones, Oleksii Rukhlenko, Tânia Dias

|Jan 03, 2025
cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling.

Hanqiang Deng, Oleksii S Rukhlenko, Divyesh Joshi

|Jul 13, 2024
Cell State Transition Models Stratify Breast Cancer Cell Phenotypes and Reveal New Therapeutic Targets.

Oleksii S Rukhlenko, Hiroaki Imoto, Ayush Tambde

Pageof 3

Frequent Collaborators

7 joint publications

Oleksii S Rukhlenko

4 joint publications

Igor Kramnik

4 joint publications

Hiroaki Imoto

4 joint publications

Alexander A Gimelbrant